Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogens

World Journal of Microbiology and Biotechnology

Volumn 28, Issue 4, 2012, Pages 1543-1552

  Bendjeddou, Kamel ^a   Fons, Michel ^b   Strocker, Pierre ^b   Sadoun, Djamila ^a  

^a UNIVERSITY OF BEJAIA   (Algeria)

^b CNRS   (France)

Author keywords

Antibacterial agents; Bacteriocins; Lactobacillus paracasei; Multidrug resistant pathogens; Purification

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL AGENT; BACTERIOCINS; CEFOTAXIME; CEFTAZIDIME; CITROBACTER FREUNDII; CLINICAL ISOLATES; ENTEROBACTER CLOACAE; GRAM-NEGATIVE BACTERIA; KLEBSIELLA OXYTOCA; LACTOBACILLUS PARACASEI; MASS SPECTROMETRY ANALYSIS; METHICILLIN; PATHOGENIC STRAINS; PH RANGE; PSEUDOMONAS AERUGINOSA; REVERSED PHASE CHROMATOGRAPHY; STAPHYLOCOCCUS AUREUS;

BACILLI; ESCHERICHIA COLI; MASS SPECTROMETRY;

PURIFICATION;

ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIOCIN;

ARTICLE; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECT; FECES; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEAT; HUMAN; INFANT; ISOLATION AND PURIFICATION; LACTOBACILLUS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MICROBIOLOGY; MOLECULAR GENETICS; MOLECULAR WEIGHT; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PH; PROTEIN STABILITY; TIME;

ANTI-BACTERIAL AGENTS; BACTERIOCINS; CHROMATOGRAPHY, LIQUID; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FECES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOT TEMPERATURE; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; LACTOBACILLUS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEIN STABILITY; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

BACTERIA (MICROORGANISMS); CITROBACTER FREUNDII; CITROBACTER KOSERI; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; LACTOBACILLUS PARACASEI; LACTOBACILLUS PARACASEI SUBSP. PARACASEI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84859268334     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-011-0958-1     Document Type: Article

References (44)

1. Atanassova M, Choiset Y, Dalgalarrondo M, Chobert JM, Dousset X, Ivanova I, Haertle T (2003) Isolation and partial biochemical characterization of a proteinaceous anti-bacteria and anti-yeast compound produced by Lactobacillus paracasei subsp. paracasei strain M3. Int J Food Microbiol 87: 63-73.
2. Beaugerie L, Petit JC (2004) Antibiotic-associated diarrhea. Best Pract Res Cl Ga 18: 337-352.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Brassart D, Shiffrin EJ (1997) The use of probiotics to reinforce mucosal defence mechanism. Trends Biochem Sci 8: 321-326.
5. Bujdakova H, Lausova A, Jankovicova S, Prodinge W, Kallova J, Milosovic P, Kettner M (1998) Study of β-lactam resistance in ceftazidime-resistant clinical isolates of Enterobacteriaceae. Int J Antimicrob Agents 10: 135-141.
6. CASFM (2010) Comite de l'antibiogramme de la société française de microbiologie. Recommandations 2010. http://www. sfm-microbiologie. org/pages/?page = 746& id_page = 182. Accessed 26 June 2011.
7. Chagnaud P, Machinis K, Coutte LA, Marecat A, Mercenier A (2001) Rapid PCR-based procedure to identify lactic acid bacteria, application to six common Lactobacillus species. J Microbiol Methods 44: 139-148.
8. Cintas LM, Rodriguez JM, Fernandez MF, Sletten K, Nes IF, Hernandez PE, Holo H (1995) Isolation and characterization of pediocin L50, a new bacteriocin from Pediococcus acidilactici with a broad inhibitory spectrum. Appl Environ Microbiol 61: 2643-2648.
9. Cintas LM, Casaus P, Håvarstein LS, Hernández PE, Nes IF (1997) Biochemical and genetic characterization of enterocin P, a novel sec dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum. Appl Environ Microbiol 63: 4321-4330.
10. Contreras BGL, De Vuyst L, Devreese B, Busanyova K, Raymaeckers J, Bosman F, Sablon E, Vandamme EJ (1997) Isolation, purification and amino acid sequence of Lactobin A, one of two bacteriocins produced by Lactobacillus amylovorus LMG P-13139. Appl Environ Microbiol 63: 13-20.
11. De Lencastre H, Duarte O, Tomasz A (2007) Antibiotic resistant Staphylococcusaureus: a paradigm of adaptive power. Curr Opin Microbiol 10: 428-435.
12. Farias LM, Totola AH, Miranda CMS, Carvalho MAR, Damasceno CAV, Tavares APC, Cisalpino EO, Vieira EC (1994) Extraction, partial purification and characterization of bacteriocin (fragilicin) produced by a strain of Bacteroides fragilis isolated form Callithrix penecillata. Res Microbiol 145: 9-16.
13. Farthing MJG, Kelly P (2007) Infectious diarrhoea. Medicine 35: 251-256.
14. 2 production, antibiotic resistance correlation with human clinical status. J Clin Microbiol 37: 729-733.
15. Ge J, Ping W, Song G, Du C, Ling H, Sun X, Gao Y (2009) Paracin 1. 7, a bacteriocin produced by Lactobacillusparacasei HD1. 7 isolated from Chinese cabbage sauerkraut, a traditional Chinese fermented vegetable food. Wei Sheng Wu Xue Bao 49: 609-616.
16. Geoff S (2005) Antibiotic resistance. Medicine 33: 47-51.
17. Gillor O, Nigro LM, Riley MA (2005) Genetically engineered bacteriocins and their potential as the next generation of antimicrobials. Curr Pharm D 11: 1067-1075.
18. Guignard B, Entenza JM, Moreillon P (2005) β-lactams against methicillin-resistant Staphylococcusaureus. Curr Opin Pharmacol 5: 479-489.
19. Jack RW, Tagg JR, Ray B (1995) Bacteriocins of Gram-positive bacteria. Microbiol Rev 59: 171-200.
20. Jacobsen CN, Rosenfeldt-Nielsen V, Hayford AE, Møller PL, Michaelsen KF, Pærregaard A, Sandstrom B, Tvede M, Jakobsen M (1999) Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65: 4949-4956.
21. Joerger MC, Klaenhammer TR (1986) Characterization and purification of helveticin J and evidence for a chromosomally determinated bacteriocin produced by Lactobacillus helveticus 481. J Bacteriol 167: 439-446.
22. Kalogeromitros D (2004) Penicillin hypersensitivity: value of clinical history and skin testing in daily practice. Allergy Asthma Proc 25: 157-160.
23. Kim CH, Ji GE, Ahn C (2000) Purification and molecular characterization of a bacteriocin from Pediococcus sp. KCA1303-10 isolated from fermented flatfish. Food Sci Biotechnol 9: 270-276.
24. Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12: 39-86.
25. Livermore DM, Woodford N (2006) The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 14: 413-420.
26. Lozo J, Jovcic B, Kojic M, Dalgalarrondo M, Chobert JM, Haertle T, Topisirovic L (2007) Molecular characterization of a novel bacteriocin and an unusually large aggregation factor of Lactobacillus paracasei subsp. paracasei BGSJ2-8, a natural isolate from homemade cheese. Curr Microbiol 55: 266-271.
27. Maidak BL, Cole JR, Parker CT, Garrity GM, Larsen N, Li B, Lilburn TG, McCaughey MJ, Olsen GJ, Overbeek R, Pramanik S, Schmidt TM, Tiedje JM, Woese CR (1999) A new version of the RDP (Ribosomal Database Project). Nucleic Acids Res 27: 171-173.
28. Marcos LA, DuPont HL (2007) Advances in defining etiology and new therapeutic approaches in acute diarrhea. J Infect 55: 385-393.
29. Netz DJA, Pohl R, Beck-Sickinger AG, Selmer T, Pierik AJ, Bastos MCF, Sahl HG (2002) Biochemical characterization and genetic analysis of Aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J Mol Biol 319: 745-756.
30. Nissen-Meyer J, Hauge HH, Fimland G, Eijsink VGH, Nes IF (1997) Ribosomally synthesized antimicrobial peptides produced by lactic acid bacteria: their function, structure, biogenesis, and their mechanism of action. Recent Res Dev Microbiol 1: 141-154.
31. Pangsomboon K, Bansal S, Martin G, Suntinanalert P, Kaewnopparat S, Srichana T (2009) Further characterization of a bacteriocin produced by Lactobacillus paracasei HL32. J Appl Microbiol 106: 1928-1940.
32. Prashar U, Bresee J, Glass R (2003) The global burden of diarrheal disease in children. Bull World Health Organ 81: 236.
33. Riley MA (1998) Molecular mechanisms of bacteriocin evolution. Annu Rev Genet 32: 255-278.
34. Rolfe RD (2000) The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130: 396-402.
35. Sahl HG, Jack RW, Bierbaum G (1995) Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur J Biochem 230: 827-853.
36. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467.
37. Servin AL, Coconnier MH (2003) Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 17: 741-754.
38. 4. Appl Environ Microbiol 58: 1952-1961.
39. Sullivan A, Edlund C, Nord CE (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1: 101-114.
40. Thomson JM, Bonomo RA (2005) The threat of antibiotic resistance in gram-negative pathogenic bacteria: β-lactams in peril. Curr Opin Microbiol 8: 518-524.
41. Tolinački M, Kojić M, Lozo J, Terzić-Vidojević A, Topisirović L, Fira D (2010) Characterization of the bacteriocin-producing strain Lactobacillus paracasei subsp. paracasei BGUB9. Arch Biol Sci 62: 889-899.
42. Topisirovic L, Kojic M, Fira D, Golic N, Strahinic I, Lozo J (2006) Potential of lactic acid bacteria isolated from specific natural niches in food production and preservation. Int J Food Microbiol 112: 230-235.
43. Verdenelli MC, Ghelfi F, Silvi S, Orpianesi C, Cecchini C, Cresci A (2009) Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces. Eur J Nutr 10: 345-353.
44. Woodford N, Livermore DM (2009) Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect 59: S4-S16.